May 17, 2020

How Faros will bring artificial technology and software to healthcare

Faros Healthcare LLC
Centerstone Research Institute
Artificial technology
Technology
Admin
2 min
Faros' software will endorse treatment plans for intricate health conditions and study patient outcomes to recommend intervention adjustments while considering the value of treatment costs.
As part of an exclusive license from Indiana University and Technology Corp, Faros Healthcare LLC will begin bringing patent-pending artificial technolo...

As part of an exclusive license from Indiana University and Technology Corp, Faros Healthcare LLC will begin bringing patent-pending artificial technology and software to healthcare providers.

Using machine learning, the software will endorse treatment plans for intricate health conditions and study patient outcomes to recommend intervention adjustments while considering the value of treatment costs.

RELATED TOPIC: Will the healthcare industry welcome artificial intelligence?

This type of data-driven technology will assist in informing clinicians and healthcare providers on patients’ response to treatment, while allowing time for adjustments.

The technology arrives at a moment when healthcare is transitioning from “fee-for-service” to “pay-for-performance approaches. Therefore, healthcare providers are being assigned to greater risk management.

RELATED TOPIC: How Australian researchers' 'bionic spine' will help paraplegics

Faros Healthcare is part of the not-for-profit organization Centerstone Research Institute, which offers community-based behavior healthcare for services in mental health, substance abuse, as well as intellectual and developmental disabilities.

President and co-founder Jim Stefansic said Faros is very excited to bring the new technology to healthcare providers.

“Faros provides a cloud-based platform that integrates with existing electronic health records and population health software to aid clinicians in achieving the best patient outcomes at an optimal cost,” said Stefansic. “Moving both sides of the cost-of-care value equation is essential in transforming our healthcare system, and we’re incredibly excited to bring this power to providers.”

RELATED TOPIC: How Australian hospitals are using video games to help patients recover

Faros co-founder Casey Bennett also served as a data architect, research fellow and data scientist at Centerstone, where his contributions to analytics and data warehousing were nationally recognized, including in IBM's Smarter Planet series.

"With this technology, we can provide clinicians and patients with not only static information about the best route to get from point A to point B, but constantly updated, real-time information about effectiveness or treatment changes during the journey," said Bennett. "It's an exciting time as data analytics and health care converge, and we look forward to transforming the way individuals receive care."

Source: IU Newsroom

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

 

 

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article